A new study from Washington University School of Medicine in St. Louis examines the choices healthy research volunteers make when given the opportunity to learn their risk of developing Alzheimer’s disease dementia. The researchers found a large discrepancy between the percentage of participants who said they would like to learn their risk if such estimates became available and the percentage who followed through to learn those results when given the actual opportunity.

When picturing a “typical” alcoholic, people tend to imagine a person drinking at home alone. But that focus overlooks the social origins of many serious alcohol problems, say the authors of a new review paper in the journal Current Directions in Psychological Science.

In a groundbreaking Genomic Press interview, Dr. Michael Wheeler of Harvard Medical School reveals how psychedelics like psilocybin can reverse stress-induced fear behaviors by modulating neuroimmune pathways. His recent Nature publication demonstrates that psychedelics reduce immune cell accumulation in brain meninges while simultaneously reducing fear behaviors, opening new therapeutic possibilities.

The study is the first to examine how substantial growth of preferred pharmacy networks maintained by PBMs may have contributed to the struggles of retail pharmacies.